Just a short note as to why we don’t share a lot of the news about cutting-edge research and breakthroughs you might find in your news feed. We’ve been amazed at how many headlines that cross our screens end up being click-bait – stories (which may be true!) from years ago, re-packaged as if they were new. There’s a story that makes the rounds from 2015 about a gal who had an islet cell transplant (from cadaver pancreases, if you read the detail) and was “cured” of type 1 diabetes! Turns out the story was written just weeks after this transplant, and with no follow-up articles in years, we figure this “cure” didn’t last. Maybe we’ll try to do some research and address the specifics in another article.

It can ruin your day to read a great headline suggesting that your long struggle may soon be over, only to find that you’re mostly a victim of the economics of clicks.

Other stories, too, are about legitimate research, but it’s still in trials or even still deep in the development stage. As much as we want to celebrate this work, our focus will remain on approved therapies or those with a legitimate timetable to come to market.